Engineers Gate Manager LP Supernus Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 14,710 shares of SUPN stock, worth $523,676. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,710
Holding current value
$523,676
% of portfolio
0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$25.77 - $35.16 $379,076 - $517,203
14,710 New
14,710 $458,000
Q1 2024

May 15, 2024
SELL
$27.11 - $35.17 $125,193 - $162,415
-4,618 Reduced 20.26%
18,174 $619,000
Q4 2023

Feb 14, 2024
BUY
$22.72 - $29.68 $517,834 - $676,466
22,792 New
22,792 $659,000
Q4 2022

Feb 14, 2023
BUY
$31.09 - $37.88 $182,436 - $222,279
5,868 New
5,868 $209,000
Q1 2021

May 17, 2021
SELL
$24.15 - $31.45 $998,771 - $1.3 Million
-41,357 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$17.7 - $25.81 $544,186 - $793,528
30,745 Added 289.72%
41,357 $1.04 Million
Q3 2020

Nov 16, 2020
SELL
$20.2 - $25.05 $198,263 - $245,865
-9,815 Reduced 48.05%
10,612 $221,000
Q2 2020

Aug 17, 2020
BUY
$17.09 - $24.89 $349,097 - $508,428
20,427 New
20,427 $485,000
Q1 2020

May 15, 2020
SELL
$14.45 - $24.69 $2.34 Million - $4 Million
-162,156 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$19.93 - $29.13 $3.23 Million - $4.72 Million
162,156 New
162,156 $3.85 Million
Q2 2019

Aug 14, 2019
SELL
$29.96 - $38.87 $1.19 Million - $1.54 Million
-39,731 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$32.77 - $41.99 $179,120 - $229,517
-5,466 Reduced 12.09%
39,731 $1.39 Million
Q4 2018

Feb 14, 2019
BUY
$30.84 - $49.51 $1.39 Million - $2.24 Million
45,197 New
45,197 $1.5 Million
Q3 2018

Nov 01, 2018
SELL
$42.7 - $56.55 $2.34 Million - $3.1 Million
-54,903 Closed
0 $0
Q2 2018

Aug 03, 2018
SELL
$44.1 - $59.85 $574,137 - $779,187
-13,019 Reduced 19.17%
54,903 $3.29 Million
Q1 2018

May 07, 2018
BUY
$37.15 - $46.9 $897,358 - $1.13 Million
24,155 Added 55.19%
67,922 $3.11 Million
Q4 2017

Feb 01, 2018
SELL
$36.4 - $42.6 $215,597 - $252,319
-5,923 Reduced 11.92%
43,767 $1.74 Million
Q3 2017

Nov 13, 2017
BUY
$36.75 - $49.65 $1.83 Million - $2.47 Million
49,690
49,690 $1.99 Million

Others Institutions Holding SUPN

# of Institutions
281
Shares Held
60.6M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email